articleThe Lancet OncologySep 19, 2011Closed access

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

Massachusetts General Hospital · Peter MacCallum Cancer Centre · +9 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

900
total citations
FWCI
103.12
Percentile
100%
References
36
Citations per year

Authors

23

Topics & keywords

Keywords
  • Crizotinib
  • Medicine
  • Internal medicine
  • Lung cancer
  • Oncology
  • Anaplastic lymphoma kinase
  • ALK inhibitor
  • Gene rearrangement
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding